HomeNews

News

Bexmarilimab Plus Vidaza Elicit Responses in Myelodysplastic Syndromes

Amongst each frontline and relapsed/refractory higher-risk myelodysplastic syndrome, remedy with bexmarilimab and Vidaza elicited excessive total response charges.Remedy with bexmarilimab and Vidaza (azacitidine)...

Early Indicators, Dangers and Key Insights

April serves as Esophageal Most cancers Consciousness Month, and has since 2009, based on the Esophageal Most cancers Motion Community. Esophageal most cancers...

Erleada Reduces Threat of Loss of life in Metastatic Prostate Most cancers Subset

Erleada decreased the danger of loss of life by greater than 20% in contrast with different remedies in metastatic castration-sensitive prostate most cancers.Amongst...

Understanding The best way to Advance Immunotherapy Technique Fashions in Melanoma

Melanoma is a key most cancers sort for growing and testing immunotherapies previous to broader medical software throughout different malignancies, Dr. Georgina Lengthy...

Subcutaneous Opdivo Equally Efficient, Protected as IV for Superior ccRCC

Subcutaneous Opdivo confirmed comparable efficacy and security to IV Opdivo in beforehand handled superior or metastatic clear cell renal cell carcinoma.Amongst sufferers with...

Hot Topics